GaryLeeClaymanMD

Head & Neck Oncologic Surgery

Alando J. Ballantyne Distinguished Chair of Head and Neck Surgery/ Medical Director

Dr. Clayman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2400 Cypress Glen Dr
Wesley Chapel, FL 33544
Phone+1 813-940-3130

Fax+1 813-315-6360

University of MinnesotaResidency, Otolaryngology - Head and Neck Surgery, 1987 - 1991
Hennepin HealthcareInternship, Transitional Year, 1986 - 1987
Northeast Ohio Medical UniversityClass of 1986

PubMed

8 citations
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.
Peter Y F Zeng, Stephenie D Prokopec, Stephen Y Lai, Nicole Pinto, Michelle A Chan-Seng-Yue
Cell Reports. 2024-03-26
97 citations
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.
Iñigo Landa, Nikita Pozdeyev, Christopher Korch, Laura A. Marlow, Robert C. Smallridge
Clinical Cancer Research. 2019-05-15
26 citations
Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.
Israel Pena, Gary L. Clayman, Elizabeth G. Grubbs, Jeffrey M. Bergeron, Steven G. Waguespack
Head & Neck. 2018-01-01

Three Years and 25,000 Patients: Hospital for Endocrine Surgery Sets Records for Thyroid, Parathyroid and Adrenal SurgeryJanuary 8th, 2025
Thyroid Cancer Survivors Celebrated by Nation's Leading Thyroid Surgeons on National Day of RecognitionOctober 22nd, 2024
Clayman Thyroid Center Performs 1000th Cancer Surgery at New Hospital for Endocrine SurgeryApril 6th, 2022
Join now to see all

Developmental Research ProgramNational Cancer Institute2008–2011
Biology Of Headpin (A Novel Serpin) In Oral CancerNational Institute Of Dental &Craniofacial Research2002–2006
Training Of Academic Head And Neck Surgical OncologistNational Cancer Institute2002–2003
Targeting The P53 Pathway For Reversal Of Oral PremalignancyNational Cancer Institute2002
Biology Of Nonmelanoma Skin Cancer Growth &ProgressionNational Cancer Institute2001–2002
Core--Central Media LaboratoryNational Cancer Institute1998–2002
Core--Tissue ProcurementNational Cancer Institute1996–2002
Apoptosis Inducing Gene Therapy For Oral PremalignancyNational Institute Of Dental &Craniofacial Research1996–2001
Developing Molecular Therapy In Head And Neck CancerNational Institute Of Dental &Craniofacial Research1996–2000